Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety, Tolerability and Efficacy of ZD6126 in Combination With Oxaliplatin, 5-Fluorouracil and Leucovorin in Subjects With Metastatic Colorectal Cancer.

NCT00065117 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00065117
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00065117 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety, Tolerability and Efficacy of ZD6126 in Combination With Oxaliplatin, 5-Fluorouracil and Leucovorin in Subjects With Metastatic Colorectal Cancer.
Lead sponsor
AstraZeneca
Phase
Phase 2
Overall status
Terminated
Start date
September 30, 2003
Completion date
February 29, 2004
Enrollment
180
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal neoplasms, metastases, neoplasm